A myristoylated pseudosubstrate peptide inhibitor of protein kinase C: Effects on glucose- and carbachol-induced insulin secretion

Molecular and Cellular Endocrinology

Volumn 121, Issue 2, 1996, Pages 133-141

  Harris, T E ^a   Persaud, S J ^a   Saermark, T ^b   Jones, P M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Insulin secretion; Islets of Langerhans; Myristoylated pseudosubstrate peptides; Protein kinase C

Indexed keywords

CARBACHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; INSULIN RELEASE; MYRISTYLATION; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

EID: 0030576631     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(96)03858-0     Document Type: Article

References (58)

1. [1] Nishizuka, Y. (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661-665.
2. [2] Nishizuka, Y. (1992) Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-613.
3. [3] Hug, H. and Sarre, T.F. (1993) Protein kinase C isoenzymes, divergence in signal transduction? Biochem. J. 291, 329-343.
4. [4] Nakamura, S. and Nishizuka, Y. (1994) Lipid mediators and protein kinase C activation for the intracellular signalling network. J. Biochem. 115, 1029-1034.
5. [5] Ito, A., Saito, N., Taniguchi, H., Chiba, T., Kikkawa, U., Saitoh, Y. and Tanaka, C. et al. (1989) Localization of βII subspecies of protein kinase C in β-cells. Diabetes 38, 1005-1011.
6. [6] Onoda, K., Hagiwara, M., Hachiya, T., Usuda, N., Nagata, T. and Hidaka H (1990) Different expression of protein kinase C isozymes in pancreatic islet cells. Endocrinology 125, 1235-1240.
7. [7] Jones, P.M., Persaud, S.J. and Howell, S.L. (1991) Protein kinase C and the regulation of insulin secretion from pancreatic β-cells. J. Mol. Endocrinol. 6, 121-127.
8. [8] Wollheim, C.B. and Regazzi, R. (1990) Protein kinase C in insulin releasing cells, putative role in stimulus-secretion coupling. FEBS Lett. 268, 376-380.
9. [9] Persaud, S.J., Jones, P.M. and Howell, S.L. (1992) The role of protein kinase C in insulin secretion. In: Flatt, P.R. (ed.), Nutrient Regulation of Insulin Secretion, Portland Press, London, pp. 247-269.
10. [10] Best, L. and Malaisse, W.J. (1983) Stimulation of phosphoinositide breakdown in rat pancreatic islets by glucose and carbamylcholine. Biochim. Biophys. Res. Commun. 116, 9-16.
11. 2+ and protein kinase C in acetylcholine-induced insulin release in the clonal β-cell line, HIT-T15. Biochem. J. 267, 227-232.
12. [12] Persaud, S.J., Jones, P.M., Sugden, D. and Howell, S.L. (1989) The role of protein kinase C in cholinergic stimulation of insulin secretion from rat islets of Langerhans. Biochem. J. 264, 753-758.
13. [13] Persaud, S.J., Jones, P.M. and Howell, S.L. (1991) Activation of protein kinase C is essential for sustained insulin secretion in response to cholinergic stimulation. Biochim. Biophys. Acta 1091, 120-122.
14. [14] Weng, L., Davies, M. and Ashcroft. S.J.H. (1993) Effects of cholinergic agonists on diacylglycerol and intracellular calcium levels in pancreatic β-cells. Cell. Signal. 5, 777-786.
15. [15] Metz, S.A. (1988) Is protein kinase C required for physiologic insulin release? Diabetes 37, 3-7.
16. [16] Soderling, T.R. (1990) Protein kinases, regulation by autoinhibitory domains. J. Biol. Chem. 265, 1823-1826.
17. [17] Kemp, B.E. and Pearson, R.B. (1991) Intrasteric regulation of protein kinases and phosphatases. Biochim. Biophys. Acta 1094, 67-76.
18. [18] Orr, J.W. and Newton, A.C. (1994) Intrapeptide regulation of protein kinase C. J. Biol. Chem. 269, 8383-8387.
19. [19] Gschwendt, M., Kittstein, W. and Marks, F. (1991) Protein kinase C activation by phorbol esters, do cysteine-rich regions and pseudosubstrate motifs play a role? Trends Biochem. Sci. 16, 167-169.
20. [20] Kemp, B.E., Pearson, R.B. and House, C.M. (1991) Pseudosubstrate-based peptide inhibitors. Methods Enzymol. 201, 287-303.
21. [21] House, C. and Kemp, B.E. (1987) Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238, 1726-1728.
22. [22] Alexander, D.R., Hexham, J.M., Lucas, S.C., Graves, J.D., Cantrell, D.A. and Crumpton, M.J. (1989) A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O-permeabilized human T lymphocytes. Biochem. J. 260, 893-901.
23. [23] Eichholtz, T., Alblas, J., Overveld, M. van, Moolenaar, W. and Ploegh, H. (1990) A pseudosubstrate peptide inhibits protein kinase C-mediated phosphorylation in permeabilized Rat-1 cells. FEBS Lett. 261, 147-150.
24. 2+/ CaM kinase II(291-317), and staurosporine. J. Biol. Chem. 265, 21179-21184.
25. [25] Basudev, H., Jones, P.M. and Howell, S.L. (1995) Protein phosphorylation in the regulation of insulin secretion, the use of site-directed inhibitory peptides in electrically permeabilised islets of Langerhans. Acta Diabetol. 32, 32-37.
26. [26] Ioannides, C.G., Freedman, R.S., Liskamp, R.M., Ward, N.E. and O'Brian, C.A. (1990) Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C. Cell. Immunol. 131, 242-252.
27. [27] Eichholtz, T., de Bont, D.B.A., de Widt, J., Liskamp, R.M.J. and Ploegh, H.L. (1993) A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268, 1982-1986.
28. [28] Barja, P., Alavi-Nassab, A., Turck, C.W. and Freire-Moar, J. (1994) Inhibition of T-cell activation by protein kinase C pseudosubstrates. Cell. Immunol. 153, 28-38.
29. [29] Saermark, T., Kleinschmidt, A., Wulff, A.M., Andreassen, H., Magee, A.M. and Erfle, V. (1991) Characterisation of N-myristoyl transferase inhibitors and their effect on human immunodeficiency virus release. AIDS 5, 951-958.
30. [30] Nielsen, N.M., Larsen, B.D. and Saermark, T. (1992) The synthesis and purification of SIV-fusion peptides. In: Epton, R. (ed.), Innovation and Perspectives in Solid Phase Synthesis and Related Technologies, Oxford University Press, pp. 64-70.
31. [31] Jones, P.M., Mann, F.M., Persaud, S.J. and Wheeler-Jones, C.P.D. (1993) Mastoparan stimulates insulin secretion from pancreatic β-cells by effects at a late stage in the secretory pathway. Mol. Cell. Endocrinol. 94, 97-103.
32. [32] Gey, G.O. and Gey, M.K. (1936) Maintenance of human normal cells in continuous culture, preliminary report; cultivation of mesoblastic tumours and normal cells and notes on methods of cultivation. Am. J. Cancer 27, 45-76.
33. 2+, cyclic AMP, a phorbol ester and noradrenaline. Biochem. J. 254, 397-403.
34. [34] Persaud, S.J., Jones, P.M., Sugden, D. and Howell, S.L. (1989) Translocation of protein kinase C in rat islets of Langerhans, Effects of a phorbol ester, carbachol and glucose. FEBS Lett. 245, 80-84.
35. [35] Persaud, S.J. and Jones, P.M. (1995) Inhibition of glucose-stimulated insulin secretion by Ro 31-8220, a protein kinase C inhibitor. Endocrine 3, 285-289.
36. [36] Gao, Z-Y., Drews, G., Nenquin, M., Plant, T.D. and Henquin, J.-C. (1990) Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets. J. Biol. Chem. 265, 15724-15730.
37. [37] Hughes, S.J., Carpinelli, A., Niki, I., Nicks, J.L. and Ashcroft, S.J.H. (1992) Stimulation of insulin release by vasopressin in the clonal β-cell line HIT-T15, the role of protein kinase C. J. Mol. Endocrinol. 8, 145-153
38. [38] Persaud, S.J., Jones, P.M. and Howell, S.L. (1993) Stimulation of insulin secretion by cholecystokinin-8S, the role of protein kinase C. Pharmacol. Commun. 3, 39-47.
39. [39] Thams, P., Capito, K., Hedeskov, C.J. and Kofod, H. (1990) Phorbol-ester-induced down-regulation of protein kinase C in mouse pancreatic islets. Potentiation of phase 1 and inhibition of phase 2 of glucose-induced insulin secretion. Biochem. J. 265, 777-787.
40. [40] Hii, C.S.T., Jones, P.M., Persaud, S.J. and Howell, S.L. (1987) A re-assessment of the role of protein kinase C in glucose-stimulated insulin secretion. Biochem. J. 246, 489-493.
41. [41] Jones, P.M., Persaud, S.J. and Howell, S.L. (1992) Insulin secretion and protein phosphorylation in PKC-depleted islets of Langerhans. Life Sci. 50, 761-767.
42. [42] Calle, R., Ganesan, S., Smallwood, J.I. and Rasmussen, H. (1992) Glucose-induced phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in isolated rat pancreatic islets. J. Biol. Chem. 267, 18723-18727.
43. [43] Ganesan, S., Calle, R., Zawalich, K., Shulman, G.I. and Rasmussen, H. (1992) Immunocytochemical localization of α-protein kinase C in rat pancreatic β-cells during glucose-induced insulin secretion. J. Cell. Biol. 119, 313-324.
44. [44] Easom, R.A., Hughes, J.H., Landt, M,. Wolf, B.A., Turk, J. and McDaniel, M.L. (1989) Comparison of effects on phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem. J. 264, 27-33.
45. [45] Thams, P., Capito, K., Hedeskov, C.J. and Kofod, H. (1986) An inhibitory role for polyamines in protein kinase C activation and insulin secretion in mouse pancreatic islets. Biochem. J. 237, 131-138.
46. [46] Hidaka, H. and Hagiwara, M. (1987) Pharmacology of the isoquinoline sulfonamide protein kinase C inhibitors. Trends Pharmacol. Sci. 8, 162-164.
47. [47] Garland, L.G., Bonser, R.W. and Thompson, N.T. (1987) Protein kinase C inhibitors are not selective. Trends Pharmacol. Sci. 8, 334.
48. [48] Rüegg, U.T. and Burgess, G.M. (1989) Staurosporine, K-252 and UCN-01, potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10, 218-220.
49. [49] Jones, P.M. and Howell, S.L. (1986) Insulin secretion studied in islets permeabilised by high voltage discharge. In: Atwater I, Rojas E, Soria B (eds.). Biophysics of the Pancreatic β-Cell, Plenum Press, NY, pp. 279-291.
50. [50] Kasahara, K. and Kikkawa, U. (1995) Distinct effects of saturated fatty acids on protein kinase C subspecies. J. Biochem. 117, 648-653.
51. [51] O'Brian, C.A., Ward, N.E., Liskamp, R.M., de Bont, D.B. and van Boom, J.H. (1990) N-myristyl-Lys-Arg-Thr-Leu-Arg, A novel protein kinase C inhibitor. Biochem. Pharmacol. 39, 49-57.
52. [52] Ward, N.E. and O'Brian, C.A. (1993) Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. Biochemistry 32, 11903-11909.
53. [53] Wheeler-Jones, C.P.D., Sayed, S. and Persaud, S.J. (1995) Effects of a myristoylated pseudosubstrate peptide inhibitor of PKC in intact human platelets. Biochem. Soc. Trans. 23, 221S.
54. [54] O'Brian, C.A., Ward, N.E., Liskamp, R.M., de Bont, D.B., Earnest, L.E., van Boom, J.H. and Fan, D. (1991) A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin. Invest. New Drugs 9, 169-179.
55. [55] Malaisse, W.J. and Sener, A. (1985) Inhibition by 1-(5-isoquinoline-sulphonyl)-2-methylpiperazine (H-7) of protein kinase C activity and insulin release in pancreatic islets. ICRS Med. Sci. 13, 1239-1240.
56. [56] Persaud, S.J., Jones, P.M. and Howell, S.L. (1991) Activation of protein kinase C is not required for glyceraldehyde-stimulated insulin secretion from rat islets. Biochim. Biophys. Acta 1095, 183-1858.
57. [57] Knutson, K.L. and Hoenig, M. (1994) Identification and subcellular characterisation of protein kinase-C isoforms in insulinoma β-cells and whole islets. Endocrinology 135, 881-886.
58. [58] Selbie, L.A., Schmitz-Peiffer, C,. Sheng, Y. and Biden, T.J. (1993) Molecular cloning and characterization of PKCi, an atypical isoform of protein kinase C derived from insulin-secreting cells. J. Biol. Chem. 268, 24296-24302.